Xencor (XNCR) Non-cash Items (2013 - 2022)
Xencor (XNCR) reported Non-cash Items of $6.4 million for Q3 2022, up 18.68% year-over-year from $5.4 million in Q3 2021, and down 80.35% quarter-over-quarter from $32.6 million in Q2 2022.
Xencor (XNCR) Non-cash Items (2013 - 2022) Analysis & Trends
Xencor (XNCR) has 10 years of Non-cash Items data on file, last reported at $6.4 million in Q3 2022.
- Non-cash Items for Q3 2022 came in at $6.4 million, up 18.68% year-over-year; the trailing twelve-month figure through Sep 2022 was $6.4 million (up 18.68% YoY), and the FY2021 annual result was $100.1 million, up 2043.38% from the prior year.
- Non-cash Items declined to $6.4 million in Q3 2022 per XNCR's latest filing, from $32.6 million in the prior quarter.
- Over five years, Non-cash Items peaked at $129.3 million in Q2 2019 and troughed at $3.6 million in Q1 2019.
- A 5-year average of $39.7 million and a median of $30.6 million in 2022 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2018 and 2020: Non-cash Items soared 43452.3% in 2018, then plunged 96.45% in 2020.
- A 5-year view of Non-cash Items shows it stood at $99.3 million in 2018, then tumbled by 96.02% to $4.0 million in 2019, then advanced by 18.15% to $4.7 million in 2020, then jumped by 2043.38% to $100.1 million in 2021, then plunged by 93.6% to $6.4 million in 2022.
- Business Quant data shows XNCR's Non-cash Items at $6.4 million in Q3 2022, $32.6 million in Q2 2022, and $30.6 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 6.40 Mn |
| Sep 30, 2022 | 6.40 Mn |
| Jun 30, 2022 | 32.59 Mn |
| Jun 30, 2022 | 32.59 Mn |
| Mar 31, 2022 | 30.63 Mn |
| Mar 31, 2022 | 30.63 Mn |
| Dec 31, 2021 | 100.06 Mn |
| Dec 31, 2021 | 100.06 Mn |
| Sep 30, 2021 | 5.39 Mn |
| Sep 30, 2021 | 5.39 Mn |
| Jun 30, 2021 | 5.27 Mn |
| Jun 30, 2021 | 5.27 Mn |
| Mar 31, 2021 | 125.40 Mn |
| Mar 31, 2021 | 125.40 Mn |
| Dec 31, 2020 | 4.67 Mn |
| Dec 31, 2020 | 4.67 Mn |
| Sep 30, 2020 | 53.70 Mn |
| Sep 30, 2020 | 53.70 Mn |
| Jun 30, 2020 | 4.59 Mn |
| Jun 30, 2020 | 4.59 Mn |